Jun 26, 2019 Maria Ohle

OrganiGram Stock: Future Plans Look Very Appealing, Shares Rise

OrganiGram stock

After hitting a lull in June, shares of OrganiGram Holdings (TSXV:OGI) (NASDAQ:OGI) are beginning to bounce back. Currently, OrganiGram stock is up 3.64% and selling for $6.27 USD on the NASDAQ.

OrganiGram Stock

It's when we look ahead at the company's future plans that interest flies.

First off, the company is well positioned to do well within the cannabis derivatives market once this area is legalized across Canada later in the year. It is generating enough capacity to ensure it can meet the expected demand for edibles and oils. Already, OrganiGram has distribution agreements will all 10 Canadian provinces, and this should make the derivatives distribution process a breeze.

In order to successfully expand beyond dried flowers and oils, the company partnered with The Green Solution and Canada's Smartest Kitchen. Both these partnerships should enhance the quality of edibles produced by the company.

Synthetic Cannabinoids

Further, OrganiGram stock soared when the company announced a partnership with Hyasynth Biologicals to produce synthetic cannabinoids at a low cost. This partnership will potentially bring strong revenue for industry arms such as cannabis-infused cosmetics and pet medicines.

>> VFF Stock Attempts to Rebound from the Recent Slump

According to analyst George Budwell:

"While dried flowers will probably always make up the bulk of the cannabis market, there's a good chance that biofermentation platforms like this one will loom large in the industry's future—especially as novel product categories like cannabis-infused cosmetics, sleep aids, and pet medicines come into their own."

International

With expanse happening at home in Canada, the company is eagerly looking towards the biggest medical cannabis market in the world—Europe. OrgnaiGram's investment in Alpha-cannabis Pharma GmbH gives it a footprint in the high-margin German cannabis space. Alongside this, the company also partnered with 1812 Hemp and Serbian-based hemp grower Eviana.

With a strong domestic footprint and a growing presence in international markets, OrganiGram stock offers a lot of potential for its $8.22 price tag. OrganiGram Holdings is relatively small with a market cap of $1.26 billion and compared to some of its peers, it is a solid performer.

>> Read More OrganiGram News

Featured Image: Canva

Please See Disclaimer

If You Liked This Article Click To Share

STOCKS YOU MAY LIKE


Disclosure:

1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Organigram Holdings Inc. Market Jar Media Inc. has or expects to receive one hundred and forty-five thousand five hundred Canadian dollars from Organigram Holdings Inc.’s agency of record Native Ads Inc. for 14 campaign days (10 business days).

3) Statements and opinions expressed are the opinions of the author and not Market Jar Media Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Market Jar Media Inc. for this Article. Market Jar Media Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Market Jar Media Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Market Jar Media Inc. relies upon the authors to accurately provide this information and Market Jar Media Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Market Jar Media Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Market Jar Media Inc. does not render general or specific investment advice and the information on Potstocknews.com should not be considered a recommendation to buy or sell any security. Market Jar Media Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on Potstocknews.com.

5) Market Jar Media Inc. and its respective directors, officers and employees hold no shares for any company mentioned in the Article.